BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4572153)

  • 41. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
    Teuffel O; Schrauder A; Sykora KW; Zimmermann M; Reiter A; Welte K; Schrappe M
    Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Trenn G; Schmidt O; Nahler M; Schaefer UW
    Bone Marrow Transplant; 1999 Apr; 23(8):771-7. PubMed ID: 10231138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Letters to the editor: Bone marrow transplantation and leukemic transformation of transplanted cells].
    Miyoshi I
    Rinsho Ketsueki; 1975 Sep; 16(9):912. PubMed ID: 175191
    [No Abstract]   [Full Text] [Related]  

  • 44. [A case of acute lymphocytic leukemia successfully treated with allogeneic bone marrow transplantation (author's transl)].
    Kodo H; Yoshida T; Funada H; Ishino C; Ishizaki T; Niwa K; Matsue K; Kanamori K; Tejima H; Hisada Y; Harada M; Nakamura S; Hattori K; Otsuki N; Tateno I
    Rinsho Ketsueki; 1980 Mar; 21(3):375-81. PubMed ID: 6997540
    [No Abstract]   [Full Text] [Related]  

  • 45. Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells.
    Kögler G; Wolf HH; Heyll A; Arkesteijn G; Wernet P
    Bone Marrow Transplant; 1995 Jan; 15(1):41-8. PubMed ID: 7742754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Frassoni F; Sanz G; Demeocq F; Prentice H; Cahn JY; Barbui T; Meloni G; Schaefer U; Reiffers J; Gorin N
    Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors affecting leukemia relapse after allogeneic BMT conditioned with cyclophosphamide and fractionated TBI.
    Zapatero A; Martín de Vidales C; Pinar B; Rodríguez F; Marín A; Cerezo L; Domínguez P; Pérez Torrubia A
    Bone Marrow Transplant; 1996 Sep; 18(3):591-6. PubMed ID: 8879623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
    Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
    Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A transient appearance of CALLA positive blastoid cells after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia].
    Komatsu N; Takagi S; Amemiya Y; Sakamoto S; Miura Y
    Rinsho Ketsueki; 1987 Feb; 28(2):250-3. PubMed ID: 2952819
    [No Abstract]   [Full Text] [Related]  

  • 52. [A case of acute lymphoblastic leukemia treated with allogeneic bone marrow transplantation from a HLA identical sibling (author's transl)].
    Takeyama H; Kawashima K; Morishima Y; Watanabe E; Hirabayashi N; Hotta T; Yamada K; Yamada H; Kurashina M; Hirabayashi N
    Rinsho Ketsueki; 1978 Oct; 19(10):1393-401. PubMed ID: 368373
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.
    Reichard KK; Zhang QY; Sanchez L; Hozier J; Viswanatha D; Foucar K
    Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term survival in unmaintained remission after allogeneic bone marrow transplantation in the treatment of acute lymphoblastic leukemia. Report of a case].
    Shiobara S; Matsue K; Yoshida T; Funada H; Harada M; Matsuda T
    Rinsho Ketsueki; 1986 Apr; 27(4):560-4. PubMed ID: 3525888
    [No Abstract]   [Full Text] [Related]  

  • 55. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
    Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
    Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone marrow transplantation in a child with acute lymphoblastic leukaemia.
    Hill RS; Mauger DC; Ockelford PA; Smith A; Beddoe A; Blacklock HA; Wilson JD; Woodfield DG; Ellis-Pegler R; Matthews JR
    N Z Med J; 1980 Feb; 91(653):83-5. PubMed ID: 6991992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic bone marrow chimerism in germfree mice. 3. Therapy of leukemic AKR mice.
    Truitt RL; Pollard M; Srivastava KK
    Proc Soc Exp Biol Med; 1974 May; 146(1):153-8. PubMed ID: 4597165
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin.
    Lawler SD; Baker MC; Harris H; Morgenstern GR
    Br J Haematol; 1984 Mar; 56(3):431-43. PubMed ID: 6365153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolated pulmonary leukemic relapse following successful bone marrow transplant in a child with acute lymphoblastic leukemia.
    Georgitis J; Eigen H; Provisor D; Baehner RL
    Pediatrics; 1979 Dec; 64(6):913-7. PubMed ID: 390489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.